Dr. Berry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Tamarack Rd
Somerset, NJ 08873Phone+1 609-865-6816Fax+1 609-818-0369
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Psychiatry, 1994 - 1998
Case Western Reserve University School of MedicineClass of 1994
Certifications & Licensure
NJ State Medical License 2016 - 2025
GA State Medical License 1998 - 2019
OH State Medical License 1995 - 1998- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 17 citationsEfficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity DisorderAnn C. Childress, Sharon B. Wigal, Matthew Brams, John M. Turnbow, Yulia Pincus
Journal of Child and Adolescent Psychopharmacology. 2017-12-06 - 18 citationsEfficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHDAdelaide S. Robb, Robert L. Findling, Ann C. Childress, Sally A. Berry, Heidi W. Belden
Journal of Attention Disorders. 2017-12-01 - 20 citationsEfficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.Sharon B. Wigal, Ann C. Childress, Sally A. Berry, Heidi W. Belden, Faith Walters
Journal of Child and Adolescent Psychopharmacology. 2017-10-01
Press Mentions
Tris Pharma Receives FDA Approval for Dyanavel XR ADHD TreatmentOctober 23rd, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
